Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertriglyceridemia: HELP
John J. P. Kastelein
Based on 15 articles published since 2008
||||
Expertise Level
The expertise of John J. P. Kastelein ranks in the
  • Top 0.032%
  • ... of 12,336 published authors worldwide on Hypertriglyceridemia
  • ... from 2008 through 2019
  • ... based on contributions to 15 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Kastelein, J J   ·   Kastelein, John J P   ·   Kastelein, John J   ·   Kastelein, J J P
Work Locations
Details
Most likely:    University of Amsterdam      
2019
  • From the Academic Medical Center, University of Amsterdam, Amsterdam. · Pubmed 30444682
2018
  • South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic, Cleveland, Ohio. · Baylor College of Medicine, Houston, Texas. · University of New South Wales, Sydney, Australia. · University of Chicago, Chicago, Illinois. · Academic Medical Center, Amsterdam, The Netherlands. · Deutsches Herzzentrum München, Technische Universität München, and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. · Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas. · Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts. · Oslo University Hospital, Oslo, Norway. · Harvard Medical School, Boston, Massachusetts. · Imperial College of London, London, UK. · Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · AstraZeneca Pharmaceuticals, Gothenburg, Sweden. · Pubmed 30125052
2016
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 27160246
  • L-MARC Research Center, Louisville, KY, USA. · Pronova BioPharma, Lysaker, Norway. · Medpace, Inc, Cincinatti, OH, USA. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: · Pubmed 26892135
2015
  • Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. Electronic address: · Amarin Pharma Inc., Bedminster, NJ, USA. · Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Academic Medical Center, Amsterdam, The Netherlands. · LipoScience, Raleigh, NC, USA. · Pubmed 26073397
2014
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. Electronic address: · Biofortis Clinical Research, Addison, IL, USA. · Russian Cardiology Scientific Production Complex, Federal State University, Moscow, Russian Federation. · Copenhagen University Hospital, University of Copenhagen, Herlev, Denmark. · Omthera Pharmaceuticals, Inc, Princeton, NJ, USA. · Pubmed 24528690
2012
  • Department of Experimental Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22239554
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 15 total) written by John J. P. Kastelein about Hypertriglyceridemia:

  • FISHing for the Miracle of Eicosapentaenoic Acid. 2019
  • Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. 2018
  • Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia. 2016
  • Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial. 2016
  • Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. 2015
  • Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study). 2015
  • Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. 2014
  • Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). 2012
  • Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). 2012
  • Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. 2012
Show List of Full Article Records
Google Searches

Learn more about John J. P. Kastelein using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Amsterdam
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Amsterdam
2019
  • From the Academic Medical Center, University of Amsterdam, Amsterdam. · Pubmed 30444682
2018
  • South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic, Cleveland, Ohio. · Baylor College of Medicine, Houston, Texas. · University of New South Wales, Sydney, Australia. · University of Chicago, Chicago, Illinois. · Academic Medical Center, Amsterdam, The Netherlands. · Deutsches Herzzentrum München, Technische Universität München, and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. · Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas. · Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts. · Oslo University Hospital, Oslo, Norway. · Harvard Medical School, Boston, Massachusetts. · Imperial College of London, London, UK. · Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · AstraZeneca Pharmaceuticals, Gothenburg, Sweden. · Pubmed 30125052
2016
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 27160246
  • L-MARC Research Center, Louisville, KY, USA. · Pronova BioPharma, Lysaker, Norway. · Medpace, Inc, Cincinatti, OH, USA. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: · Pubmed 26892135
2015
  • Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. Electronic address: · Amarin Pharma Inc., Bedminster, NJ, USA. · Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Academic Medical Center, Amsterdam, The Netherlands. · LipoScience, Raleigh, NC, USA. · Pubmed 26073397
2014
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. Electronic address: · Biofortis Clinical Research, Addison, IL, USA. · Russian Cardiology Scientific Production Complex, Federal State University, Moscow, Russian Federation. · Copenhagen University Hospital, University of Copenhagen, Herlev, Denmark. · Omthera Pharmaceuticals, Inc, Princeton, NJ, USA. · Pubmed 24528690
2012
  • Department of Experimental Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22239554
Unspecified
2015
  • From the Department of Medicine, Université de Montréal and Ecogene-21 Clinical Research Centre, Chicoutimi, QC, Canada (D.G., D.B., K.T.) · Isis Pharmaceuticals, Carlsbad (V.J.A., B.F.B., W.S., R.S.G., S.G.H., N.J.V., M.J.G., R.M.C.), and the Department of Medicine, University of California, San Diego, La Jolla (J.L.W.) - both in California · the Department of Medicine, University of Washington, Seattle (J.D.B.) · and the Department of Vascular Medicine, Academic Medical Center, Amsterdam (J.J.P.K.). · Pubmed 26222559
6 Other Locations Show
Yearly article counts 110221031121
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.